Karow A - Search Results

1

Integrated care in patients with schizophrenia: results of trials published between 2011 and 2013 focusing on effectiveness and efficiency.

Schöttle D, Karow A, Schimmelmann BG, Lambert M. Schöttle D, et al. Among authors: karow a. Curr Opin Psychiatry. 2013 Jul;26(4):384-408. doi: 10.1097/YCO.0b013e328361ec3b. Curr Opin Psychiatry. 2013. PMID: 23722100 Review.

2

Subjective well-being and quality of life under atypical antipsychotic treatment.

Karow A, Naber D. Karow A, et al. Psychopharmacology (Berl). 2002 Jun;162(1):3-10. doi: 10.1007/s00213-002-1052-z. Epub 2002 Apr 20. Psychopharmacology (Berl). 2002. PMID: 12107610 Review.

3

Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

Haasen C, Lambert M, Yagdiran O, Karow A, Krausz M, Naber D. Haasen C, et al. Among authors: karow a. Int Clin Psychopharmacol. 2003 Mar;18(2):113-5. doi: 10.1097/00004850-200303000-00009. Int Clin Psychopharmacol. 2003. PMID: 12598824

4

Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.

Lambert M, Schimmelmann BG, Karow A, Naber D. Lambert M, et al. Among authors: karow a. Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S181-90. doi: 10.1055/s-2003-45128. Pharmacopsychiatry. 2003. PMID: 14677077 Review.

5

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D. Lambert M, et al. Among authors: karow a. Eur Psychiatry. 2004 Nov;19(7):415-22. doi: 10.1016/j.eurpsy.2004.06.031. Eur Psychiatry. 2004. PMID: 15504648

6

[Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].

Naber D, Lambert M, Karow A. Naber D, et al. Among authors: karow a. Psychiatr Prax. 2004 Nov;31 Suppl 2:S230-2. doi: 10.1055/s-2004-828486. Psychiatr Prax. 2004. PMID: 15586315 Review. German.

7

Subjective well-being under the neuroleptic treatment and its relevance for compliance.

Naber D, Karow A, Lambert M. Naber D, et al. Among authors: karow a. Acta Psychiatr Scand Suppl. 2005;(427):29-34. doi: 10.1111/j.1600-0447.2005.00542.x. Acta Psychiatr Scand Suppl. 2005. PMID: 15943008 Review.

8

PANSS syndromes and quality of life in schizophrenia.

Karow A, Moritz S, Lambert M, Schoder S, Krausz M. Karow A, et al. Psychopathology. 2005 Nov-Dec;38(6):320-6. doi: 10.1159/000088921. Epub 2005 Oct 12. Psychopathology. 2005. PMID: 16224206

9

Insight and quality of life in schizophrenia: recent findings and treatment implications.

Karow A, Pajonk FG. Karow A, et al. Curr Opin Psychiatry. 2006 Nov;19(6):637-41. doi: 10.1097/01.yco.0000245754.21621.c9. Curr Opin Psychiatry. 2006. PMID: 17012945 Review.

10

Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.

Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T, Czekalla J. Lambert M, et al. Among authors: karow a. J Clin Psychiatry. 2006 Nov;67(11):1690-7. doi: 10.4088/jcp.v67n1104. J Clin Psychiatry. 2006. PMID: 17196047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters